对比增强磁共振血管成像与数字减影血管造影在弹簧圈栓塞治疗颅内动脉瘤随访中的临床价值:闭塞分级评估及对治疗决策的影响
回顾性分析92例患者102个弹簧圈栓塞动脉瘤,比较3 T ceMRA与DSA按MRRC和Meyers分级的一致性及治疗决策。两种方法评估闭塞分级一致性良好(MRRC κ=0.64,Meyers κ=0.74),治疗决策一致性极好(κ=0.92)。ceMRA极少漏诊有意义的动脉瘤残留,可能适合作为首选随访方法;但残留增大或复发时可能需补充DSA指导治疗决策。
要点
- ceMRA与DSA评估弹簧圈栓塞动脉瘤的MRRC和Meyers分级一致性良好至很好。
- 两种方法对治疗/随访决策的一致性极好(κ=0.92)。
- ceMRA发现 interval 动脉瘤增大19例,多于DSA的16例。
核心结论
- ceMRA极少漏诊有意义的动脉瘤残留,可能适合作为首选随访方法。
- 当ceMRA检测到残留增大或复发时,可能需补充DSA以指导治疗决策。
研究设计与样本
- 回顾性识别接受弹簧圈栓塞的动脉瘤患者,随访检查同时包含DSA和3 T ceMRA。
- 共纳入92例患者、102个弹簧圈栓塞动脉瘤。
- 盲法阅片,两种方法均按改良Raymond-Roy分级(MRRC)和Meyers分级进行评估,并要求阅片者根据影像表现做出再治疗/随访决策。
诊断标准与关键数值
- DSA与ceMRA的MRRC一致性κ=0.64,Meyers分级一致性κ=0.74。
- 动脉瘤闭塞<90%(Meyers分级≥2)的一致性κ=0.87。
- 检测弹簧圈团与动脉瘤壁之间存在对比剂的残留(MRRC IIIb)有12处不一致,一致性κ=0.70。
- 治疗/随访决策一致性κ=0.92。
- 7例治疗决策不一致的患者中,综合评估两种方法后作者同意DSA 4例、同意ceMRA 3例。
临床应用与阅片要点
- ceMRA可作为弹簧圈栓塞动脉瘤随访的首选影像方法,可能消除常规DSA的需要。
- 当ceMRA检测到动脉瘤残留增大或复发时,可能需补充DSA以指导治疗决策。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: The aim of this study was a detailed analysis of the value of contrast-enhanced magnetic resonance angiography (ceMRA) compared to digital subtraction angiography (DSA) for follow-up imaging of intracranial aneurysms treated by coil embolization.
METHODS: Patients with coiled aneurysms and follow-up exams including both DSA and 3 T ceMRA were retrospectively identified. In blinded readings, both modalities were graded according to the modified Raymond-Roy classification (MRRC) and the Meyers scale. Additionally, readers were asked to make a decision regarding retreatment/follow-up based on the respective imaging findings.
RESULTS: The study comprised 92 patients harboring 102 coiled aneurysms. There was good intermethod agreement of DSA and ceMRA concerning both the MRRC (κ = 0.64) and the Meyers scale (κ = 0.74). Agreement regarding occlusion of < 90% of the aneurysm (Meyers grade ≥ 2) was very good (κ = 0.87). Regarding the detection of a remnant with contrast between the coil mass and the aneurysm wall (MRRC IIIb), there were 12 discrepant findings and agreement was good (κ = 0.70). Comparing treatment/follow-up decisions, the two methods agreed very well (κ = 0.92). In seven patients with discrepant treatment decisions, the authors concurred with DSA in four cases and with ceMRA in three cases when evaluating both modalities together. Interval aneurysm growth was found in more cases with ceMRA (n = 19) than with DSA (n = 16).
CONCLUSIONS: CeMRA is very unlikely to miss a relevant aneurysm remnant and thus could be suitable as the primary follow-up method. In case of remnant growth or recurrence, however, additional DSA might be required to guide treatment decisions.
KEY POINTS: • There is high accordance between ceMRA and DSA regarding the evaluation of intracranial aneurysms treated by endovascular coil embolization, but closer analysis also revealed relevant differences. • CeMRA could be suitable as the primary follow-up imaging modality, potentially eliminating the need for routine DSA. • DSA will still be required in case of aneurysm remnant growth or recurrence as detected by ceMRA.
引用
- Patzig M, Forbrig R, Gruber M, et al. The clinical value of ceMRA versus DSA for follow-up of intracranial aneurysms treated by coil embolization: an assessment of occlusion classifications and impact on treatment decisions. Eur Radiol. 2020. PMID: 33221944. doi:10.1007/s00330-020-07492-3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。